WallStSmart
VCYT

Veracyte Inc

NASDAQ: VCYT · HEALTHCARE · DIAGNOSTICS & RESEARCH

$32.92
+3.59% today

Updated 2026-04-30

Market cap
$2.67B
P/E ratio
40.77
P/S ratio
5.16x
EPS (TTM)
$0.82
Dividend yield
52W range
$23 – $51
Volume
0.9M

Veracyte Inc (VCYT) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item201120122013201420152016201720182019202020212022202320242025
Operating cash flow$-13.52M$-7.17M$-19.16M$-27.63M$-26.96M$-27.98M$-23.91M$-13.52M$-3.23M$-9.71M$-31.62M$7.54M$44.22M$75.10M$136.31M
Capital expenditures$276000.00$1.46M$1.33M$2.02M$6.17M$4.21M$1.75M$1.87M$2.76M$2.84M$5.38M$8.55M$9.96M$11.29M$9.68M
Depreciation$611000.00$706000.00$999000.00$1.18M$2.25M$3.51M$3.84M$3.92M$4.12M$7.94M$19.59M$25.93M$27.19M$23.46M
Stock-based comp$659000.00$934000.00$1.25M$3.55M$5.60M$6.38M$6.62M$5.96M$9.81M$12.99M$22.52M$26.73M$33.14M$36.25M$43.60M
Free cash flow$-13.80M$-8.63M$-20.49M$-29.66M$-33.13M$-32.19M$-25.67M$-15.39M$-5.99M$-12.55M$-37.00M$-1.01M$34.26M$63.81M$126.63M
Investing cash flow$-331000.00$-1.46M$-1.28M$-9.01M$-6.70M$-4.21M$-1.20M$-1.87M$-42.73M$-3.84M$-739.21M$-29.39M$15.11M$-56.27M
Financing cash flow$18.65M$15.06M$77.66M$436000.00$37.73M$52.33M$-218000.00$59.50M$127.29M$203.59M$596.32M$3.49M$2.84M$4.90M
Dividends paid$0.00$9.27M$0.00$0.00$0.00$977000.00$3.85M$3.17M
Share repurchases
Debt repayment
Net change in cash$57.22M$-36.21M$4.07M$20.14M$-25.33M$44.10M$81.32M$190.05M$-174.51M$-18.36M